Prenatal multivitamin mineral supplement
Dietary Supplementprenatal vitamin/mineral supplement with or without choline supplement
Other names: Prenatal multivitamin mineral supplement plus choline supplement
NCT Number: NCT03782935
Interventional study randomizing pregnant women at two sites in Ukraine who have or have not already consumed moderate to heavy levels of alcohol in pregnancy to receiving a standard prenatal vitamin supplement with or without additional choline supplement or standard of care (recommendation to take vitamin supplements) through the remainder of pregnancy, and to compare neurobehavioral performance of the offspring on the Bayley Scales of Infant Development at 12 months of age between groups. The overall sample size target was 300 alcohol exposed and 300 low or unexposed across both sites.
Looking for future studies?
Notify MeFemale
Interventional
Not applicable
Pregnant women coming in for routine prenatal diagnostic testing or prenatal care at two sites in Ukraine, Rivne Diagnostic Center or Khmelnytsky Regional Perinatal Center, were screened for alcohol consumption during pregnancy. Those who met the criteria of consuming 4-5 drinks per occasion on 3-4 occasions in either the month around conception or the most recent month of pregnancy were eligible for recruitment into the alcohol exposed group, and the next available woman who consumed no more than 2 drinks on any occasion in the month around conception or the most recent month of pregnancy was eligible for recruitment into the alcohol low or no exposure group. Within alcohol group and within site, women were randomized on a 1:1 basis to receiving a study-provided prenatal vitamin (TheraVit) manufactured in the U.S. and registered in Ukraine as an over-the-counter product, or to receiving standard of care which is obstetric advice to take prenatal vitamins on their own. Within the group randomized to receiving the prenatal vitamins, women were further randomized on a 1:1 basis to receiving an additional 750 mg. of supplemental choline manufactured in the U.S., and registered in Ukraine as an over-the-counter product.
Women in both cohorts were followed until delivery and those with live born children were followed until the child reached one year of age. The primary endpoint for the intervention was performance on the mental developmental index (MDI) and the psychomotor developmental index (PDI) components of the Bayley Scales of Infant Development II. The Bayley tests were administered at approximately 12 months adjusted chronological age by trained psychologists in Ukraine.
The primary comparison for the study was within the alcohol-exposed group, comparing mean Bayley scores on MDI and separately on PDI between those randomized to receiving the study prenatal vitamin and those randomized to standard of care.
Secondary comparisons for the study examined
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
prenatal vitamin/mineral supplement with or without choline supplement
Other names: Prenatal multivitamin mineral supplement plus choline supplement
Time frame: approximately 12 months of age adjusted for preterm delivery
Scaled score range 50 to 150 with higher scores indicating better performance
Time frame: approximately 12 months of age adjusted for preterm delivery
Scaled score range 50 to 150 with higher scores indicating better performance
University of California, San Diego
Other
Early Identification of Affected Children and Nutritional Risk Factors for FASD in Ukraine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06471335
Alcohol-Induced Disorders, Alcohol-Related Disorders
Saint-Denis, France
View Trial DetailsNCT05028517
Alcohol-Induced Disorders, Alcohol-Related Disorders
Rochester, New York, United States
View Trial DetailsNCT04332172
Alcohol-Induced Disorders, Alcohol-Related Disorders
Flint, Michigan, United States
View Trial DetailsNCT05986565
Alcohol-Induced Disorders, Alcohol-Related Disorders
Rochester, New York, United States
View Trial Details